M.-L. Bennasar et al. / Tetrahedron: Asymmetry 13 (2002) 95–106
103
3.39, 3.45 (2 br s, 1H, 15-H), 3.63 (m, 2H, 6-H), 4.02,
4.12 (2t, 1H, 3-H), 4.22, 4.79 (2s, 1H, 16-H), 4.80 (m,
1H, 3%-H), 5.49 (m, 1H, 19-H), 6.30 (s, 1H, 7-H),
7.01–7.65 (m, 9H, Ar); 13C NMR (major diastereomer,
assignment aided by HMQC) l 12.7 (C-18), 21.7, 26.1
27.7 (C-7%, C-9%, C-10%), 26.7 (C-5%), 27.6 (C-14), 31.3
(C-1%, C-15), 34.2 (C-6%), 39.7 (C-8%), 41.3 (C-2%), 50.1
(C-4%), 51.8 (C-3), 54.2 (C-5), 56.3 (C-21), 57.7 (C-6),
59.7 (C-16), 77.6 (C-3%), 101.4 (C-7), 109.2 (C-12),
120.1, 120.6, 121.3, 121.5 (indole, C-19), 125.3–128.1
(Ph), 128.6 (C-8), 131.8, 134.9, 137.4 (C-2, C-13, C-20),
151.3 (Ph), 169.1 (CO); HRMS calcd for C35H44N2O3
540.3351, found 540.3353.
J=15.4 Hz, 1H, 18-H), 6.46 (s, 1H, 21-H), 6.48 (s, 1H,
7-H), 6.58 (d, J=1.3 Hz, 1H, 16-H), 7.06–7.28 (m, 9H,
Ar, 19-H), 7.59 (d, J=7.5 Hz, 1H, 9-H); 13C NMR
(assignment aided by HMQC) l 20.8 (COMe), 22.0
(C-14), 28.8 (C-15), 37.1 (CH2Ph), 48.7 (C-3), 51.1
(OMe), 51.5 (C-5), 56.2 (C-4), 58.2 (C-16), 61.8 (C-6),
66.6 (C-5%), 99.7 (C-7), 105.1 (C-18), 105.4 (C-20),
109.1 (C-12), 120.7 (C-9), 121.0 (C-10), 122.4 (C-11),
128.0 (C-8), 127.3, 128.8, 129.4, 134.5 (Ph), 135.5 (C-
2), 137.0 (C-13), 144.9 (C-21), 145.3 (C-19), 152.9,
169.2, 170.7 (CO). Anal. calcd for C33H33N3O7·H2O: C,
65.88; H, 5.86; N, 6.98. Found: C, 65.82; H, 5.77; N,
7.00%.
4.15. Methyl (1R*,2S*,6S*)-5-(2-acetoxyethyl)-1-[(4S)-
isopropyl-2-oxo-1,3-oxazolidinylcarbonyl]-1,2,5,6-tetra-
hydro-2,6-methano[1,4]diazocino[1,2-a]indole-(3E)-
acrylate 8d
4.14. Methyl (1R*,2S*,6S*)-5-(2-acetoxyethyl)-1-[(4S)-
benzyl-2-oxo-1,3-oxazolidinylcarbonyl]-1,2,5,6-tetra-
hydro-2,6-methano[1,4]diazocino[1,2-a]indole-(3E)-
acrylate 8c
Operating as in the preparation of tetracycles 8a, from
oxazolidinone 6d (0.37 g, 1.3 mmol), and pyridinium
iodide 7 (0.49 g, 1.29 mmol), a residue was obtained
and then chromatographed. Elution with 1:1 hexanes–
AcOEt afforded tetracycle 8d (70 mg, 13%, minor
diastereomer); mp 158°C (Et2O–hexanes); [h]2D2 +849 (c
0.5, CHCl3); IR (KBr) 1777, 1737, 1698, 1582; 1H
NMR l 0.87, 0.93 (2d, J=6.8 Hz, 6H), 1.90 (dt,
J=13.1, 3.3 Hz, 1H), 2.08 (s, 3H), 2.25 (m, 1H), 2.45
(dt, J=13.1, 2.5 Hz, 1H), 3.20 (m, 1H), 3.25 (br s, 1H),
3.61 (dt, J=16, 4.5 Hz, 1H), 3.74 (s, 3H), 4.11 (m,
1H), 4.39 (m, 4H), 4.60 (br s, 1H), 6.05 (d, J=15 Hz,
1H), 6.44, 6.46 (2s, 2H), 6.56 (s, 1H, 16-H), 7.10–7.26
(m, 4H), 7.60 (d, J=7.8 Hz, 1H); 13C NMR l 15.0,
17.7 (CH3), 20.8 (CH3), 21.9 (CH2), 28.4 (CH), 29.2
(CH), 48.7 (CH), 51.1 (CH3), 51.6 (CH2), 58.2 (CH),
58.9 (CH), 61.7 (CH2), 64.2 (CH2), 99.8 (CH), 105.4
(CH), 105.5 (C), 109.7 (CH), 120.7 (CH), 121.0 (CH),
122.5 (CH), 128.1 (C), 135.4 (C), 137.3 (C), 144.9
(CH), 145.4 (CH), 153.7, 169.4, 170.5 (C). Anal. calcd
for C29H33N3O7·1/2H2O: C, 63.96; H, 6.29; N, 7.72.
Found: C, 64.03; H, 6.65; N, 7.43%. Elution with 4:6
hexane–AcOEt afforded tetracycle 8d (98 mg, 18%,
major diastereomer); mp 195°C (Et2O–hexanes); [h]D22
−962 (c 0.5, CHCl3); IR (film) 1778, 1738, 1697, 1582;
1H NMR (assignment aided by HMQC) l 0.75, 0.80
(2d, J=7 Hz, 6H, CH3), 1.86 (dt, J=13, 3 Hz, 1H,
14-H), 2.06 (s, 3H, COMe), 2.11 (m, 1H, CH), 2.61 (dt,
J=13, 2.4 Hz, 1H, 14-H), 3.20 (m, 2H, 15-H, 5-H),
3.60 (dt, J=15, 4 Hz, 1H, 5-H), 3.72 (s, 3H, OMe),
4.11 (m, 1H, 6-H), 4.35 (m, 4H, 4%-H, 5%-H, 6-H), 4.60
(br s, 1H, 3-H), 5.94 (d, J=15 Hz, 1H, 18-H), 6.43,
6.46 (2s, 2H, 21-H, 7-H), 6.57 (s, 1H, 16-H), 7.06–7.25
(m, 4H, indole, 19-H), 7.55 (d, J=7.8 Hz, 1H, 9-H);
13C NMR (assignment aided by HMQC) l 14.1, 17.7
(Me), 20.8 (MeCO), 21.9 (C-14), 27.6 (CH), 28.5 (C-
15), 48.7 (C-3), 51.0 (OMe), 51.5 (C-5), 58.1 (C-16),
59.2 (C-4%), 61.7 (C-6), 63.6 (C-5%), 99.6 (C-7), 105.3
(C-18), 105.5 (C-20), 109.0 (C-12), 120.7 (C-9), 121.0
(C-10), 122.3 (C-11), 128.1 (C-8), 135.5 (C-2), 136.9
(C-13), 144.9 (C-21), 145.4 (C-19), 156.6, 169.3, 170.4,
170.7 (CO).
Oxazolidinone 6c (0.3 g, 0.89 mmol) was allowed to
react with LDA (0.97 mmol) in THF (30 mL) at −78°C
for 30 min, and then with pyridinium iodide 7 (0.34 g,
0.89 mmol) as described for the preparation of tetra-
cycles 8a. After the usual workup, the resulting residue
was chromatographed. Elution with 1:1 hexanes–
AcOEt afforded tetracycle 8c (62 mg, 12%, minor
diastereomer); mp 166°C (Et2O–hexanes); [h]2D2 +508 (c
1, CHCl3), +471 (c 0.5, acetone); IR (KBr) 1778, 1736,
1698, 1581; ms, m/z (rel. intensity) 583 (M+, 18), 379
(100); 1H NMR (500 MHz, assignment aided by
NOESY and HMQC) l 1.86 (dt, J=13, 3.2 Hz, 1H,
14-H), 2.07 (s, 3H, COMe), 2.47 (dt, J=13, 2.7 Hz,
1H, 14-H), 2.73 (dd, J=13.2, 9.5 Hz, 1H, CH2Ph),
3.18 (m, 1H, 15-H), 3.20 (m, 2H, CH2Ph and 5-H),
3.59 (dt, J=15, 4.1 Hz, 1H, 5-H), 3.73 (s, 3H, OMe),
4.12 (m, 1H, 6-H), 4.26 (m, 2H, 5%-H), 4.15 (m, 1H,
6-H), 4.60 (br s, 1H, 3-H), 4.63 (m, 1H, 4%-H), 5.98 (d,
J=15.4 Hz, 1H, 18-H), 6.44, 6.45 (2s, 2H, 21-H, 7-H),
6.53 (d, J=1.6 Hz, 1H, 16-H), 7.06–7.32 (m, 9H, Ar,
19-H), 7.57 (dm, J=8 Hz, 1H, 9-H); 13C NMR (assign-
ment aided by HMQC) l 20.8 (MeCO), 21.9 (C-14),
28.8 (C-15), 38.3 (CH2Ph), 48.7 (C-3), 51.0 (OMe), 51.5
(C-5), 54.8 (C-4%), 58.5 (C-16), 61.8 (C-6), 67.3 (C-5%),
99.8 (C-7), 105.3 (C-20), 105.4 (C-18), 108.9 (C-12),
120.7 (C-9), 121.0 (C-10), 122.5 (C-11), 128.1 (C-8),
127.5, 128.1, 128.9, 134.5 (Ph), 135.5 (C-2), 144.9 (C-
21), 145.3 (C-19), 153.2, 169.3, 170.6 (CO), 170.7 (CO).
Anal. calcd for C33H33N3O7: C, 67.91; H, 5.69; N, 7.20.
Found: C, 67.80; H, 5.76; N, 7.13%. Elution with 4:6
hexane–AcOEt afforded tetracycle 8c (93 mg, 18%,
major diastereomer); [h]2D2 −539 (c 1, CHCl3), −387.6 (c
0.5, acetone); IR (KBr) 1778, 1737, 1696, 1578; ms,
1
m/z (rel. intensity) 583 (M+, 15), 379 (100); H NMR
(500 MHz, assignment aided by NOESY and HMQC)
l 1.91 (dt, J=13, 3.5 Hz, 1H, 14-H), 2.09 (s, 3H,
COMe), 2.64 (dt, J=13, 2.5 Hz, 1H, 14-H), 2.70 (dd,
J=13.5, 9.5 Hz, 1H, CH2Ph), 3.02 (dd, J=14, 2.5 Hz,
1H, CH2Ph), 3.20 (br s, 1H, 15-H), 3.24 (m, 1H, 5-H),
3.64 (dt, J=15, 4.4 Hz, 1H, 5-H), 3.71 (s, 3H, OMe),
4.15 (m, 1H, 6-H), 4.30 (m, 2H, 5%-H), 4.40 (m, 1H,
6-H), 4.57 (m, 1H, 4%-H), 4.64 (br s, 1H, 3-H), 5.87 (d,